Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial
Authors
Keywords
Community-based care, Hepatitis C virus, Randomized controlled trial, Protocol
Journal
Trials
Volume 19, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-07-16
DOI
10.1186/s13063-018-2768-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Direct Acting Antivirals Improve HCV Treatment Initiation and Adherence Among Underserved African Americans
- (2018) Kendall R. Beck et al. Annals of Hepatology
- Hepatitis C: global epidemiology and strategies for control
- (2016) S. Lanini et al. CLINICAL MICROBIOLOGY AND INFECTION
- Multidisciplinary managed care networks-Life-saving interventions for hepatitis C patients
- (2016) J. M. Tait et al. JOURNAL OF VIRAL HEPATITIS
- Treatment of Chronic Hepatitis C Infection among Current And Former Injection Drug Users within a Multidisciplinary Treatment Model at a Community Health Centre
- (2016) Adam I Newman et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States
- (2015) Soumitri Barua et al. ANNALS OF INTERNAL MEDICINE
- The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service
- (2015) Amanda J. Wade et al. PLoS One
- Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward)
- (2014) G. J. Dore et al. JOURNAL OF VIRAL HEPATITIS
- Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
- (2014) Ira M Jacobson et al. LANCET
- Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
- (2014) Kris V. Kowdley et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Treatment Cascade for Chronic Hepatitis C Virus Infection in the United States: A Systematic Review and Meta-Analysis
- (2014) Baligh R. Yehia et al. PLoS One
- Safety and Effectiveness of a Nurse-Led Outreach Program for Assessment and Treatment of Chronic Hepatitis C in the Custodial Setting
- (2013) Andrew R. Lloyd et al. CLINICAL INFECTIOUS DISEASES
- Understanding Barriers to Hepatitis C Virus Care and Stigmatization From a Social Perspective
- (2013) Carla Treloar et al. CLINICAL INFECTIOUS DISEASES
- Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals
- (2013) Natasha K. Martin et al. HEPATOLOGY
- Effectiveness-implementation Hybrid Designs
- (2012) Geoffrey M. Curran et al. MEDICAL CARE
- Developing a Modified Directly Observed Therapy Intervention for Hepatitis C Treatment in a Methadone Maintenance Program: Implications for Program Replication
- (2012) R. Douglas Bruce et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews
- (2011) Paul K Nelson et al. LANCET
- Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers
- (2011) Sanjeev Arora et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started